Berberine ameliorates nonalcoholic fatty liver disease-induced bone loss by inhibiting ferroptosis.
Gu S, Wang J, Yu S, Zhang S, Gao T, Yan D, Xie R, Gu M, Yu M, Zhang Z, Lou Z, Ding X, Chen Y, Li C.
Gu S, et al. Among authors: ding x.
Bone. 2024 May 7;185:117114. doi: 10.1016/j.bone.2024.117114. Online ahead of print.
Bone. 2024.
PMID: 38723878